ArticleCureus2026
Association of the TSHR Gene Intronic Single Nucleotide Polymorphism rs2268458 With Non-autoimmune Hypothyroidism: A Hospital-Based Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Nonautoimmune hypothyroidism is underexplored despite its potential metabolic and muscular complications. This study investigated the thyroid-stimulating hormone receptor (TSHR) intronic single nucleotide polymorphism (SNP) rs2268458 to assess its association with non-autoimmune hypothyroidism in an Indian population. Methods A hospital-based cross-sectional study was conducted between May 2023 and July 2024 and included 36 patients with non-autoimmune hypothyroidism, 22 healthy controls, and 13 autoimmune hypothyroid patients (positive controls). Thyroid function (T3, T4, and thyroid-stimulating hormone (TSH)) and anti-thyroid peroxidase (anti-TPO) antibody levels were measured using electrochemiluminescence immunoassay. Genotyping of the TSHR rs2268458 polymorphism was performed using PCR-restriction fragment length polymorphism (PCR-RFLP) and confirmed by Sanger sequencing. Genotype and allele frequencies were analyzed in relation to thyroid biochemical parameters. Results The patients showed significantly higher TSH and lower T3 levels than controls (p < 0.05), along with elevated T4 levels. Anti-TPO antibody levels were substantially lower than those observed in autoimmune hypothyroid patients. The TC genotype was the most frequent among patients (52.78%), whereas healthy controls demonstrated a higher frequency of the CC genotype. Genotype distribution differed between patients and controls, with predominance of the TC genotype among patients. Conclusion The TSHR intronic SNP rs2268458 may be associated with non-autoimmune hypothyroidism, with predominance of the TC genotype among affected individuals. These findings suggest a possible role of TSHR genetic variation in disease susceptibility independent of overt autoimmunity. Further large-scale and functional studies are required to validate these observations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.